This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Adds quantum molecular modeling and simulation to the list of research topics under the federal quantum information science program, directing federal research efforts to include quantum-based molecular modeling and simulation. Describes potential benefits of quantum molecular modeling for faster, more accurate study of chemical reactions and materials that could help drug design, fertilizer production, energy storage, stronger/lighter metals, protective materials, and new superconductors.
The bill aims to accelerate drug discovery and commercial materials/energy advances by funding quantum molecular modeling — boosting long‑term economic, health, and infrastructure benefits — but raises near‑term fiscal, access, security, and civil‑liberty risks as public funds and early gains may be
Patients and the general public could get faster development of new drugs because federal support and focus on quantum molecular modeling accelerate drug discovery and shorten time-to-market.
Consumers, manufacturers, and farmers could see lower costs and better products as faster molecular simulations enable improved batteries and energy storage, higher‑capacity materials, more efficient fertilizers, and other commercial innovations.
Researchers, universities, and national labs will gain federal support to build quantum molecular modeling and simulation capability, strengthening U.S. scientific capacity and workforce development.
Taxpayers may shoulder increased federal research spending and new research priorities without offsets, putting pressure on the federal budget.
Near-term consumer and public benefits could be delayed because initial gains (new drugs, materials, fertilizers, devices) may primarily accrue to companies and patent holders before becoming broadly accessible or affordable.
Advanced molecular simulation capabilities could enable dual-use technologies that raise national security risks if commercialized or misused.
Introduced March 2, 2026 by Randy Feenstra · Last progress March 2, 2026